Randolph C. Read, Director at ENZON PHARMACEUTICALS, INC. (ENZN), bought 100,450 shares at $0.15 ($16K) on 2020-11-16, disclosed to the SEC on 2020-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.15 | 50,450 | $8K | 48.6% |
| 2 | $0.16 | 50,000 | $8K | 51.4% |
| Total | $0.15 avg | 100,450 | $16K | 100% |
| Filing → |